nodes	percent_of_prediction	percent_of_DWPC	metapath
Tapentadol—UGT2B7—Epirubicin—sarcoma	0.45	0.921	CbGbCtD
Tapentadol—CYP2D6—Doxorubicin—sarcoma	0.0386	0.0791	CbGbCtD
Tapentadol—Nervous system disorder—Vincristine—sarcoma	0.00158	0.0031	CcSEcCtD
Tapentadol—Decreased appetite—Thiotepa—sarcoma	0.00158	0.0031	CcSEcCtD
Tapentadol—Menopausal symptoms—Epirubicin—sarcoma	0.00158	0.00309	CcSEcCtD
Tapentadol—Anaphylactic shock—Mitoxantrone—sarcoma	0.00157	0.00308	CcSEcCtD
Tapentadol—Oedema—Mitoxantrone—sarcoma	0.00157	0.00308	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Thiotepa—sarcoma	0.00157	0.00308	CcSEcCtD
Tapentadol—Decreased appetite—Dactinomycin—sarcoma	0.00157	0.00307	CcSEcCtD
Tapentadol—Fatigue—Thiotepa—sarcoma	0.00157	0.00307	CcSEcCtD
Tapentadol—Infection—Mitoxantrone—sarcoma	0.00156	0.00306	CcSEcCtD
Tapentadol—Hyperhidrosis—Vincristine—sarcoma	0.00156	0.00305	CcSEcCtD
Tapentadol—Fatigue—Dactinomycin—sarcoma	0.00156	0.00305	CcSEcCtD
Tapentadol—Constipation—Thiotepa—sarcoma	0.00156	0.00305	CcSEcCtD
Tapentadol—Shock—Mitoxantrone—sarcoma	0.00155	0.00303	CcSEcCtD
Tapentadol—Tachycardia—Mitoxantrone—sarcoma	0.00154	0.003	CcSEcCtD
Tapentadol—Skin disorder—Mitoxantrone—sarcoma	0.00153	0.00299	CcSEcCtD
Tapentadol—Lethargy—Epirubicin—sarcoma	0.00152	0.00298	CcSEcCtD
Tapentadol—Hyperhidrosis—Mitoxantrone—sarcoma	0.00152	0.00297	CcSEcCtD
Tapentadol—Hypotension—Vincristine—sarcoma	0.00151	0.00295	CcSEcCtD
Tapentadol—Feeling abnormal—Thiotepa—sarcoma	0.0015	0.00294	CcSEcCtD
Tapentadol—Osteoarthritis—Epirubicin—sarcoma	0.00149	0.00292	CcSEcCtD
Tapentadol—Feeling abnormal—Dactinomycin—sarcoma	0.00149	0.00291	CcSEcCtD
Tapentadol—Hot flush—Doxorubicin—sarcoma	0.00148	0.00289	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Vincristine—sarcoma	0.00147	0.00288	CcSEcCtD
Tapentadol—Hypotension—Mitoxantrone—sarcoma	0.00147	0.00287	CcSEcCtD
Tapentadol—Menopausal symptoms—Doxorubicin—sarcoma	0.00146	0.00286	CcSEcCtD
Tapentadol—Insomnia—Vincristine—sarcoma	0.00146	0.00286	CcSEcCtD
Tapentadol—Paraesthesia—Vincristine—sarcoma	0.00145	0.00284	CcSEcCtD
Tapentadol—Urticaria—Thiotepa—sarcoma	0.00145	0.00283	CcSEcCtD
Tapentadol—Vertigo—Etoposide—sarcoma	0.00144	0.00282	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.00143	0.0028	CcSEcCtD
Tapentadol—Paraesthesia—Mitoxantrone—sarcoma	0.00141	0.00276	CcSEcCtD
Tapentadol—Loss of consciousness—Etoposide—sarcoma	0.00141	0.00276	CcSEcCtD
Tapentadol—Lethargy—Doxorubicin—sarcoma	0.00141	0.00276	CcSEcCtD
Tapentadol—Decreased appetite—Vincristine—sarcoma	0.0014	0.00275	CcSEcCtD
Tapentadol—Ataxia—Epirubicin—sarcoma	0.0014	0.00274	CcSEcCtD
Tapentadol—Dyspnoea—Mitoxantrone—sarcoma	0.0014	0.00274	CcSEcCtD
Tapentadol—Cough—Etoposide—sarcoma	0.0014	0.00274	CcSEcCtD
Tapentadol—Somnolence—Mitoxantrone—sarcoma	0.0014	0.00273	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Vincristine—sarcoma	0.00139	0.00273	CcSEcCtD
Tapentadol—Fatigue—Vincristine—sarcoma	0.00139	0.00272	CcSEcCtD
Tapentadol—Convulsion—Etoposide—sarcoma	0.00139	0.00272	CcSEcCtD
Tapentadol—Dyspepsia—Mitoxantrone—sarcoma	0.00138	0.00271	CcSEcCtD
Tapentadol—Constipation—Vincristine—sarcoma	0.00138	0.0027	CcSEcCtD
Tapentadol—Osteoarthritis—Doxorubicin—sarcoma	0.00138	0.0027	CcSEcCtD
Tapentadol—Decreased appetite—Mitoxantrone—sarcoma	0.00137	0.00267	CcSEcCtD
Tapentadol—Fatigue—Mitoxantrone—sarcoma	0.00136	0.00265	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.00136	0.00265	CcSEcCtD
Tapentadol—Breast disorder—Epirubicin—sarcoma	0.00135	0.00264	CcSEcCtD
Tapentadol—Constipation—Mitoxantrone—sarcoma	0.00135	0.00263	CcSEcCtD
Tapentadol—Aspartate aminotransferase increased—Epirubicin—sarcoma	0.00134	0.00263	CcSEcCtD
Tapentadol—Hypersensitivity—Thiotepa—sarcoma	0.00134	0.00262	CcSEcCtD
Tapentadol—Nasopharyngitis—Epirubicin—sarcoma	0.00133	0.00261	CcSEcCtD
Tapentadol—Hypersensitivity—Dactinomycin—sarcoma	0.00133	0.0026	CcSEcCtD
Tapentadol—Confusional state—Etoposide—sarcoma	0.00132	0.00258	CcSEcCtD
Tapentadol—Alanine aminotransferase increased—Epirubicin—sarcoma	0.00132	0.00257	CcSEcCtD
Tapentadol—Anaphylactic shock—Etoposide—sarcoma	0.00131	0.00256	CcSEcCtD
Tapentadol—Asthenia—Thiotepa—sarcoma	0.00131	0.00256	CcSEcCtD
Tapentadol—Infection—Etoposide—sarcoma	0.0013	0.00254	CcSEcCtD
Tapentadol—Ataxia—Doxorubicin—sarcoma	0.0013	0.00254	CcSEcCtD
Tapentadol—Asthenia—Dactinomycin—sarcoma	0.0013	0.00254	CcSEcCtD
Tapentadol—Feeling abnormal—Mitoxantrone—sarcoma	0.0013	0.00254	CcSEcCtD
Tapentadol—Pruritus—Thiotepa—sarcoma	0.00129	0.00252	CcSEcCtD
Tapentadol—Tachycardia—Etoposide—sarcoma	0.00128	0.0025	CcSEcCtD
Tapentadol—Skin disorder—Etoposide—sarcoma	0.00127	0.00249	CcSEcCtD
Tapentadol—Hyperhidrosis—Etoposide—sarcoma	0.00127	0.00247	CcSEcCtD
Tapentadol—Urticaria—Mitoxantrone—sarcoma	0.00125	0.00244	CcSEcCtD
Tapentadol—Breast disorder—Doxorubicin—sarcoma	0.00125	0.00244	CcSEcCtD
Tapentadol—Diarrhoea—Thiotepa—sarcoma	0.00125	0.00244	CcSEcCtD
Tapentadol—Aspartate aminotransferase increased—Doxorubicin—sarcoma	0.00124	0.00243	CcSEcCtD
Tapentadol—Diarrhoea—Dactinomycin—sarcoma	0.00124	0.00242	CcSEcCtD
Tapentadol—Nasopharyngitis—Doxorubicin—sarcoma	0.00123	0.00241	CcSEcCtD
Tapentadol—Hypotension—Etoposide—sarcoma	0.00122	0.00239	CcSEcCtD
Tapentadol—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.00122	0.00238	CcSEcCtD
Tapentadol—Dizziness—Thiotepa—sarcoma	0.0012	0.00236	CcSEcCtD
Tapentadol—Upper respiratory tract infection—Epirubicin—sarcoma	0.0012	0.00234	CcSEcCtD
Tapentadol—Pollakiuria—Epirubicin—sarcoma	0.00119	0.00233	CcSEcCtD
Tapentadol—Hypersensitivity—Vincristine—sarcoma	0.00119	0.00233	CcSEcCtD
Tapentadol—Paraesthesia—Etoposide—sarcoma	0.00118	0.0023	CcSEcCtD
Tapentadol—Weight decreased—Epirubicin—sarcoma	0.00117	0.00228	CcSEcCtD
Tapentadol—Dyspnoea—Etoposide—sarcoma	0.00117	0.00228	CcSEcCtD
Tapentadol—Somnolence—Etoposide—sarcoma	0.00116	0.00227	CcSEcCtD
Tapentadol—Hypersensitivity—Mitoxantrone—sarcoma	0.00116	0.00227	CcSEcCtD
Tapentadol—Asthenia—Vincristine—sarcoma	0.00116	0.00227	CcSEcCtD
Tapentadol—Vomiting—Thiotepa—sarcoma	0.00116	0.00226	CcSEcCtD
Tapentadol—Infestation NOS—Epirubicin—sarcoma	0.00115	0.00225	CcSEcCtD
Tapentadol—Infestation—Epirubicin—sarcoma	0.00115	0.00225	CcSEcCtD
Tapentadol—Vomiting—Dactinomycin—sarcoma	0.00115	0.00225	CcSEcCtD
Tapentadol—Rash—Thiotepa—sarcoma	0.00115	0.00225	CcSEcCtD
Tapentadol—Dermatitis—Thiotepa—sarcoma	0.00115	0.00224	CcSEcCtD
Tapentadol—Headache—Thiotepa—sarcoma	0.00114	0.00223	CcSEcCtD
Tapentadol—Rash—Dactinomycin—sarcoma	0.00114	0.00223	CcSEcCtD
Tapentadol—Decreased appetite—Etoposide—sarcoma	0.00114	0.00222	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Etoposide—sarcoma	0.00113	0.00221	CcSEcCtD
Tapentadol—Asthenia—Mitoxantrone—sarcoma	0.00113	0.00221	CcSEcCtD
Tapentadol—Fatigue—Etoposide—sarcoma	0.00113	0.00221	CcSEcCtD
Tapentadol—Constipation—Etoposide—sarcoma	0.00112	0.00219	CcSEcCtD
Tapentadol—Urinary tract infection—Epirubicin—sarcoma	0.00112	0.00219	CcSEcCtD
Tapentadol—Upper respiratory tract infection—Doxorubicin—sarcoma	0.00111	0.00217	CcSEcCtD
Tapentadol—Diarrhoea—Vincristine—sarcoma	0.00111	0.00216	CcSEcCtD
Tapentadol—Pollakiuria—Doxorubicin—sarcoma	0.0011	0.00216	CcSEcCtD
Tapentadol—Nausea—Thiotepa—sarcoma	0.00108	0.00212	CcSEcCtD
Tapentadol—Weight decreased—Doxorubicin—sarcoma	0.00108	0.00211	CcSEcCtD
Tapentadol—Feeling abnormal—Etoposide—sarcoma	0.00108	0.00211	CcSEcCtD
Tapentadol—Diarrhoea—Mitoxantrone—sarcoma	0.00108	0.0021	CcSEcCtD
Tapentadol—Nausea—Dactinomycin—sarcoma	0.00107	0.0021	CcSEcCtD
Tapentadol—Dizziness—Vincristine—sarcoma	0.00107	0.00209	CcSEcCtD
Tapentadol—Infestation NOS—Doxorubicin—sarcoma	0.00106	0.00208	CcSEcCtD
Tapentadol—Infestation—Doxorubicin—sarcoma	0.00106	0.00208	CcSEcCtD
Tapentadol—Bradycardia—Epirubicin—sarcoma	0.00105	0.00206	CcSEcCtD
Tapentadol—Urticaria—Etoposide—sarcoma	0.00104	0.00203	CcSEcCtD
Tapentadol—Urinary tract infection—Doxorubicin—sarcoma	0.00103	0.00202	CcSEcCtD
Tapentadol—Hypoaesthesia—Epirubicin—sarcoma	0.00103	0.00201	CcSEcCtD
Tapentadol—Vomiting—Vincristine—sarcoma	0.00103	0.00201	CcSEcCtD
Tapentadol—Urinary tract disorder—Epirubicin—sarcoma	0.00102	0.00199	CcSEcCtD
Tapentadol—Rash—Vincristine—sarcoma	0.00102	0.00199	CcSEcCtD
Tapentadol—Dermatitis—Vincristine—sarcoma	0.00102	0.00199	CcSEcCtD
Tapentadol—Connective tissue disorder—Epirubicin—sarcoma	0.00101	0.00198	CcSEcCtD
Tapentadol—Urethral disorder—Epirubicin—sarcoma	0.00101	0.00198	CcSEcCtD
Tapentadol—Headache—Vincristine—sarcoma	0.00101	0.00198	CcSEcCtD
Tapentadol—Vomiting—Mitoxantrone—sarcoma	0.001	0.00196	CcSEcCtD
Tapentadol—Visual impairment—Epirubicin—sarcoma	0.000995	0.00195	CcSEcCtD
Tapentadol—Rash—Mitoxantrone—sarcoma	0.000992	0.00194	CcSEcCtD
Tapentadol—Dermatitis—Mitoxantrone—sarcoma	0.000991	0.00194	CcSEcCtD
Tapentadol—Headache—Mitoxantrone—sarcoma	0.000986	0.00193	CcSEcCtD
Tapentadol—Bradycardia—Doxorubicin—sarcoma	0.000973	0.0019	CcSEcCtD
Tapentadol—Eye disorder—Epirubicin—sarcoma	0.000965	0.00189	CcSEcCtD
Tapentadol—Hypersensitivity—Etoposide—sarcoma	0.000964	0.00189	CcSEcCtD
Tapentadol—Nausea—Vincristine—sarcoma	0.00096	0.00188	CcSEcCtD
Tapentadol—Cardiac disorder—Epirubicin—sarcoma	0.000958	0.00187	CcSEcCtD
Tapentadol—Hypoaesthesia—Doxorubicin—sarcoma	0.000951	0.00186	CcSEcCtD
Tapentadol—Urinary tract disorder—Doxorubicin—sarcoma	0.000943	0.00184	CcSEcCtD
Tapentadol—Asthenia—Etoposide—sarcoma	0.000939	0.00184	CcSEcCtD
Tapentadol—Connective tissue disorder—Doxorubicin—sarcoma	0.000939	0.00184	CcSEcCtD
Tapentadol—Angiopathy—Epirubicin—sarcoma	0.000937	0.00183	CcSEcCtD
Tapentadol—Urethral disorder—Doxorubicin—sarcoma	0.000936	0.00183	CcSEcCtD
Tapentadol—Nausea—Mitoxantrone—sarcoma	0.000934	0.00183	CcSEcCtD
Tapentadol—Immune system disorder—Epirubicin—sarcoma	0.000933	0.00182	CcSEcCtD
Tapentadol—Mediastinal disorder—Epirubicin—sarcoma	0.000931	0.00182	CcSEcCtD
Tapentadol—Chills—Epirubicin—sarcoma	0.000926	0.00181	CcSEcCtD
Tapentadol—Pruritus—Etoposide—sarcoma	0.000926	0.00181	CcSEcCtD
Tapentadol—Visual impairment—Doxorubicin—sarcoma	0.000921	0.0018	CcSEcCtD
Tapentadol—Mental disorder—Epirubicin—sarcoma	0.000905	0.00177	CcSEcCtD
Tapentadol—Malnutrition—Epirubicin—sarcoma	0.000899	0.00176	CcSEcCtD
Tapentadol—Diarrhoea—Etoposide—sarcoma	0.000895	0.00175	CcSEcCtD
Tapentadol—Eye disorder—Doxorubicin—sarcoma	0.000893	0.00175	CcSEcCtD
Tapentadol—Cardiac disorder—Doxorubicin—sarcoma	0.000887	0.00173	CcSEcCtD
Tapentadol—Tension—Epirubicin—sarcoma	0.000882	0.00172	CcSEcCtD
Tapentadol—Nervousness—Epirubicin—sarcoma	0.000873	0.00171	CcSEcCtD
Tapentadol—Angiopathy—Doxorubicin—sarcoma	0.000867	0.00169	CcSEcCtD
Tapentadol—Dizziness—Etoposide—sarcoma	0.000865	0.00169	CcSEcCtD
Tapentadol—Immune system disorder—Doxorubicin—sarcoma	0.000863	0.00169	CcSEcCtD
Tapentadol—Mediastinal disorder—Doxorubicin—sarcoma	0.000861	0.00168	CcSEcCtD
Tapentadol—Chills—Doxorubicin—sarcoma	0.000857	0.00168	CcSEcCtD
Tapentadol—Vision blurred—Epirubicin—sarcoma	0.000847	0.00166	CcSEcCtD
Tapentadol—Mental disorder—Doxorubicin—sarcoma	0.000837	0.00164	CcSEcCtD
Tapentadol—Vomiting—Etoposide—sarcoma	0.000832	0.00163	CcSEcCtD
Tapentadol—Malnutrition—Doxorubicin—sarcoma	0.000832	0.00163	CcSEcCtD
Tapentadol—Agitation—Epirubicin—sarcoma	0.000826	0.00162	CcSEcCtD
Tapentadol—Rash—Etoposide—sarcoma	0.000825	0.00161	CcSEcCtD
Tapentadol—Dermatitis—Etoposide—sarcoma	0.000824	0.00161	CcSEcCtD
Tapentadol—Headache—Etoposide—sarcoma	0.00082	0.0016	CcSEcCtD
Tapentadol—Tension—Doxorubicin—sarcoma	0.000816	0.0016	CcSEcCtD
Tapentadol—Nervousness—Doxorubicin—sarcoma	0.000808	0.00158	CcSEcCtD
Tapentadol—Vertigo—Epirubicin—sarcoma	0.000808	0.00158	CcSEcCtD
Tapentadol—Syncope—Epirubicin—sarcoma	0.000806	0.00158	CcSEcCtD
Tapentadol—Palpitations—Epirubicin—sarcoma	0.000794	0.00155	CcSEcCtD
Tapentadol—Loss of consciousness—Epirubicin—sarcoma	0.00079	0.00154	CcSEcCtD
Tapentadol—Cough—Epirubicin—sarcoma	0.000784	0.00153	CcSEcCtD
Tapentadol—Vision blurred—Doxorubicin—sarcoma	0.000784	0.00153	CcSEcCtD
Tapentadol—Convulsion—Epirubicin—sarcoma	0.000779	0.00152	CcSEcCtD
Tapentadol—Nausea—Etoposide—sarcoma	0.000777	0.00152	CcSEcCtD
Tapentadol—Arthralgia—Epirubicin—sarcoma	0.000765	0.0015	CcSEcCtD
Tapentadol—Agitation—Doxorubicin—sarcoma	0.000764	0.00149	CcSEcCtD
Tapentadol—Anxiety—Epirubicin—sarcoma	0.000763	0.00149	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.00076	0.00149	CcSEcCtD
Tapentadol—Dry mouth—Epirubicin—sarcoma	0.000748	0.00146	CcSEcCtD
Tapentadol—Vertigo—Doxorubicin—sarcoma	0.000747	0.00146	CcSEcCtD
Tapentadol—Syncope—Doxorubicin—sarcoma	0.000746	0.00146	CcSEcCtD
Tapentadol—Confusional state—Epirubicin—sarcoma	0.00074	0.00145	CcSEcCtD
Tapentadol—Palpitations—Doxorubicin—sarcoma	0.000735	0.00144	CcSEcCtD
Tapentadol—Anaphylactic shock—Epirubicin—sarcoma	0.000734	0.00143	CcSEcCtD
Tapentadol—Oedema—Epirubicin—sarcoma	0.000734	0.00143	CcSEcCtD
Tapentadol—Loss of consciousness—Doxorubicin—sarcoma	0.000731	0.00143	CcSEcCtD
Tapentadol—Infection—Epirubicin—sarcoma	0.000729	0.00142	CcSEcCtD
Tapentadol—Cough—Doxorubicin—sarcoma	0.000726	0.00142	CcSEcCtD
Tapentadol—Shock—Epirubicin—sarcoma	0.000722	0.00141	CcSEcCtD
Tapentadol—Convulsion—Doxorubicin—sarcoma	0.000721	0.00141	CcSEcCtD
Tapentadol—Nervous system disorder—Epirubicin—sarcoma	0.000719	0.00141	CcSEcCtD
Tapentadol—Tachycardia—Epirubicin—sarcoma	0.000716	0.0014	CcSEcCtD
Tapentadol—Skin disorder—Epirubicin—sarcoma	0.000713	0.00139	CcSEcCtD
Tapentadol—Hyperhidrosis—Epirubicin—sarcoma	0.000709	0.00139	CcSEcCtD
Tapentadol—Arthralgia—Doxorubicin—sarcoma	0.000708	0.00138	CcSEcCtD
Tapentadol—Anxiety—Doxorubicin—sarcoma	0.000706	0.00138	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000703	0.00137	CcSEcCtD
Tapentadol—Dry mouth—Doxorubicin—sarcoma	0.000692	0.00135	CcSEcCtD
Tapentadol—Hypotension—Epirubicin—sarcoma	0.000685	0.00134	CcSEcCtD
Tapentadol—Confusional state—Doxorubicin—sarcoma	0.000684	0.00134	CcSEcCtD
Tapentadol—Anaphylactic shock—Doxorubicin—sarcoma	0.000679	0.00133	CcSEcCtD
Tapentadol—Oedema—Doxorubicin—sarcoma	0.000679	0.00133	CcSEcCtD
Tapentadol—Infection—Doxorubicin—sarcoma	0.000674	0.00132	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000668	0.00131	CcSEcCtD
Tapentadol—Shock—Doxorubicin—sarcoma	0.000668	0.00131	CcSEcCtD
Tapentadol—Nervous system disorder—Doxorubicin—sarcoma	0.000666	0.0013	CcSEcCtD
Tapentadol—Insomnia—Epirubicin—sarcoma	0.000663	0.0013	CcSEcCtD
Tapentadol—Tachycardia—Doxorubicin—sarcoma	0.000662	0.0013	CcSEcCtD
Tapentadol—Skin disorder—Doxorubicin—sarcoma	0.000659	0.00129	CcSEcCtD
Tapentadol—Paraesthesia—Epirubicin—sarcoma	0.000659	0.00129	CcSEcCtD
Tapentadol—Hyperhidrosis—Doxorubicin—sarcoma	0.000656	0.00128	CcSEcCtD
Tapentadol—Dyspnoea—Epirubicin—sarcoma	0.000654	0.00128	CcSEcCtD
Tapentadol—Somnolence—Epirubicin—sarcoma	0.000652	0.00128	CcSEcCtD
Tapentadol—Dyspepsia—Epirubicin—sarcoma	0.000646	0.00126	CcSEcCtD
Tapentadol—Decreased appetite—Epirubicin—sarcoma	0.000638	0.00125	CcSEcCtD
Tapentadol—Hypotension—Doxorubicin—sarcoma	0.000634	0.00124	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Epirubicin—sarcoma	0.000633	0.00124	CcSEcCtD
Tapentadol—Fatigue—Epirubicin—sarcoma	0.000632	0.00124	CcSEcCtD
Tapentadol—Constipation—Epirubicin—sarcoma	0.000627	0.00123	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000618	0.00121	CcSEcCtD
Tapentadol—Insomnia—Doxorubicin—sarcoma	0.000614	0.0012	CcSEcCtD
Tapentadol—Paraesthesia—Doxorubicin—sarcoma	0.000609	0.00119	CcSEcCtD
Tapentadol—Dyspnoea—Doxorubicin—sarcoma	0.000605	0.00118	CcSEcCtD
Tapentadol—Feeling abnormal—Epirubicin—sarcoma	0.000604	0.00118	CcSEcCtD
Tapentadol—Somnolence—Doxorubicin—sarcoma	0.000603	0.00118	CcSEcCtD
Tapentadol—Dyspepsia—Doxorubicin—sarcoma	0.000597	0.00117	CcSEcCtD
Tapentadol—Decreased appetite—Doxorubicin—sarcoma	0.00059	0.00115	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000586	0.00115	CcSEcCtD
Tapentadol—Fatigue—Doxorubicin—sarcoma	0.000585	0.00114	CcSEcCtD
Tapentadol—Urticaria—Epirubicin—sarcoma	0.000583	0.00114	CcSEcCtD
Tapentadol—Constipation—Doxorubicin—sarcoma	0.00058	0.00113	CcSEcCtD
Tapentadol—Feeling abnormal—Doxorubicin—sarcoma	0.000559	0.00109	CcSEcCtD
Tapentadol—Hypersensitivity—Epirubicin—sarcoma	0.00054	0.00106	CcSEcCtD
Tapentadol—Urticaria—Doxorubicin—sarcoma	0.000539	0.00105	CcSEcCtD
Tapentadol—Asthenia—Epirubicin—sarcoma	0.000526	0.00103	CcSEcCtD
Tapentadol—Pruritus—Epirubicin—sarcoma	0.000519	0.00101	CcSEcCtD
Tapentadol—Diarrhoea—Epirubicin—sarcoma	0.000502	0.000981	CcSEcCtD
Tapentadol—Hypersensitivity—Doxorubicin—sarcoma	0.0005	0.000978	CcSEcCtD
Tapentadol—Asthenia—Doxorubicin—sarcoma	0.000487	0.000952	CcSEcCtD
Tapentadol—Dizziness—Epirubicin—sarcoma	0.000485	0.000948	CcSEcCtD
Tapentadol—Pruritus—Doxorubicin—sarcoma	0.00048	0.000939	CcSEcCtD
Tapentadol—Vomiting—Epirubicin—sarcoma	0.000466	0.000912	CcSEcCtD
Tapentadol—Diarrhoea—Doxorubicin—sarcoma	0.000464	0.000908	CcSEcCtD
Tapentadol—Rash—Epirubicin—sarcoma	0.000463	0.000904	CcSEcCtD
Tapentadol—Dermatitis—Epirubicin—sarcoma	0.000462	0.000904	CcSEcCtD
Tapentadol—Headache—Epirubicin—sarcoma	0.00046	0.000899	CcSEcCtD
Tapentadol—Dizziness—Doxorubicin—sarcoma	0.000449	0.000878	CcSEcCtD
Tapentadol—Nausea—Epirubicin—sarcoma	0.000436	0.000852	CcSEcCtD
Tapentadol—Vomiting—Doxorubicin—sarcoma	0.000432	0.000844	CcSEcCtD
Tapentadol—Rash—Doxorubicin—sarcoma	0.000428	0.000837	CcSEcCtD
Tapentadol—Dermatitis—Doxorubicin—sarcoma	0.000428	0.000836	CcSEcCtD
Tapentadol—Headache—Doxorubicin—sarcoma	0.000425	0.000831	CcSEcCtD
Tapentadol—Nausea—Doxorubicin—sarcoma	0.000403	0.000788	CcSEcCtD
